BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25487850)

  • 1. [Temporary recommendation for use on off-label baclofen: viewpoint of Prescribers of the CAMTEA system].
    Rolland B; Deheul S; Danel T; Bence C; Blanquart MC; Bonord A; Semal R; Briand T; Sochala M; Dubocage C; Dupriez F; Duquesne D; Gibour B; Loosfeld X; Henebelle D; Henon M; Vernalde E; Matton C; Bacquet JE; Molmy L; Sarasy F; Simioni N; Richez C; Gentil-Spinosi L; Vosgien V; Yguel J; Ledent T; Auffret M; Wilquin M; Ziolkowski D; Sochala M; Gautier S; Bordet R; Cottencin O;
    Therapie; 2015; 70(2):235-8. PubMed ID: 25487850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Involvement of pharmacists in systems for supervising off-label medications: example of the CAMTEA system for the prescription of baclofen in alcohol use disorder in Northern France].
    Auffret M; Rolland B; Deheul S; Lecomte L; Cottencin O; Bordet R; Gautier S;
    Ann Pharm Fr; 2014 Jan; 72(1):28-32. PubMed ID: 24438666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.
    Auffret M; Rolland B; Caous AS; Gaboriau L; Deheul S; Bordet R; Gautier S
    Fundam Clin Pharmacol; 2018 Apr; 32(2):234-238. PubMed ID: 29143356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey.
    Rolland B; Paille F; Fleury B; Cottencin O; Benyamina A; Aubin HJ
    PLoS One; 2014; 9(6):e98062. PubMed ID: 24887094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baclofen for alcohol dependence in France: incidence of treated patients and prescription patterns--a cohort study.
    Dupouy J; Fournier JP; Jouanjus É; Palmaro A; Poutrain JC; Oustric S; Lapeyre-Mestre M
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):192-9. PubMed ID: 24139234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Addictions, alcoholism and baclofen: latest French news].
    Nau JY
    Rev Med Suisse; 2014 Jun; 10(435):1366-7. PubMed ID: 25051604
    [No Abstract]   [Full Text] [Related]  

  • 7. [Baclofen and liver cirrhosis: literature review and safety precautions implemented within the system CAMTEA].
    Rolland B; Deheul S; Louvet A; Gautier S; Cottencin O; Bordet R;
    Therapie; 2014; 69(2):143-7. PubMed ID: 24926632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
    Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B
    Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A system of prescriptions without drug approval: example of baclofen].
    Rolland B; Deheul S; Danel T; Bordet R; Cottencin O
    Therapie; 2010; 65(6):511-8. PubMed ID: 21176757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes of community pharmacists to off-label prescribing of baclofen in Northern France.
    Auffret M; Rolland B; Caous AS; Deheul S; Béné J; Cottencin O; Bordet R; Gautier S
    Int J Clin Pharm; 2015 Apr; 37(2):296-9. PubMed ID: 25666941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
    Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
    Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death of an alcohol-dependent patient following intentional drug intoxication: implication of baclofen?
    Pape E; Roman E; Scala-Bertola J; Thivilier C; Javot L; Saint-Marcoux F; Jouzeau JY; Gambier N
    Eur Addict Res; 2014; 20(6):300-4. PubMed ID: 25300747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use in France of Baclofen for Alcohol Dependence from 2007 to 2013: Cohort Study Based on the Databases SNIIRAM and PMSI].
    Chaignot C; Weill A; Ricordeau P; Alla F
    Therapie; 2015; 70(5):443-53. PubMed ID: 26423143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment.
    Rolland B; Auffret M; Franchitto N
    Expert Opin Drug Saf; 2016 Jun; 15(6):747-51. PubMed ID: 26987987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label psychotropic prescribing for young persons in medium security.
    Haw C; Stubbs J
    J Psychopharmacol; 2010 Oct; 24(10):1491-8. PubMed ID: 19423609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlicensed and off-label drug use in a neonatal unit in France.
    Nguyen KA; Claris O; Kassai B
    Acta Paediatr; 2011 Apr; 100(4):615-7. PubMed ID: 21410525
    [No Abstract]   [Full Text] [Related]  

  • 17. A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France.
    Auffret M; Rolland B; Béhal H; Labreuche J; Jouanjus E; Bordet R; Gautier S
    Therapie; 2019 Dec; 74(6):645-650. PubMed ID: 31277890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol.
    Rolland B; Auffret M; Labreuche J; Lapeyre-Mestre M; Dib M; Kemkem A; Grit I; Drelon M; Duhamel A; Cabe N; Vabret F; Guillin O; Baguet A; Masquelier C; Dervaux A; Deheul S; Bordet R; Carton L; Cottencin O; Jardri R; Gautier S
    Expert Opin Drug Saf; 2017 Feb; 16(2):125-132. PubMed ID: 27984918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: "Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France".
    Braillon A
    Drug Saf; 2017 Apr; 40(4):359-360. PubMed ID: 28185069
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose baclofen for treatment-resistant alcohol dependence.
    Pastor A; Jones DM; Currie J
    J Clin Psychopharmacol; 2012 Apr; 32(2):266-8. PubMed ID: 22367662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.